Hospice Care Execs Dodge Shareholders' Medicare Fraud Suit

By Jody Godoy · May 12, 2016, 7:14 PM EDT

A Delaware federal judge on Thursday dismissed investors' claims that current and former executives at Chemed Corp.'s hospice care business breached their duty to prevent Medicare fraud, saying the complaint doesn't...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum and Order

Case Information

Case Title

In RE: Chemed Corporation, Shareholder Derivative Litigation

Case Number

Court

Delaware

Nature of Suit

Stockholders Suits

Date Filed

November 06, 2013

Recent Articles By Jody

July 21, 2020
2 Chinese Nationals Accused Of Hacking COVID-19 Research
June 30, 2020
Ex-Indivior CEO Cops To Misdemeanor In Opioid Case
June 29, 2020
Feds Say Atty Exploited Rural Hospitals To Cover $1.4B Fraud
June 25, 2020
Novartis Units Pay $346M Over US Bribery Claims
May 11, 2020
Feds Float Added Charge Against Ex-Theranos CEO
April 10, 2020
2nd Circ. Won't Rehear Deerfield Insider Trading Appeal
April 01, 2020
2nd Circ. Rejects Sheldon Silver's Bid To Delay Sentencing
March 31, 2020
Ex-Theranos CEO Wants Trial Prep OK'd Amid Pandemic
March 30, 2020
Patient Recruiter Got Kickbacks For COVID-19 Tests, Feds Say
March 04, 2020
Cross-Border Probes Slowing Amid Coronavirus Precautions